Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CB | P42338 | 4/20 | 0.49 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.49 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.49 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.49 |
| ▸ | MTOR | P42345 | 1/20 | 0.49 |
| ▸ | RAB27A | P51159 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 11/20 | 0.41 |
| ▸ | KDR | P35968 | 11/20 | 0.41 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23966018 | 0.95 | PIK3CB (0.49) | PIK3CBPIK3CDPIK3CAPIK3CGCHRM2 | |
| SCHEMBL24211172 | 0.94 | PIK3CB (0.49) | PIK3CBPIK3CDPIK3CAPIK3CGCHRM2 | |
| SCHEMBL23966084 | 0.92 | PIK3CB (0.58) | PIK3CBPIK3CDPIK3CAPIK3CGCHRM2 | |
| SCHEMBL23965924 | 0.91 | PIK3CB (0.51) | PIK3CBPIK3CDPIK3CAPIK3CGCHRM2 | |
| SCHEMBL24211091 | 0.91 | PIK3CB (0.45) | PIK3CBPIK3CDPIK3CAPIK3CGCHRM2 | |
| SCHEMBL23966057 | 0.90 | PIK3CB (0.45) | PIK3CBPIK3CDPIK3CAPIK3CGCHRM2 | |
| SCHEMBL24211133 | 0.89 | PIK3CB (0.40) | PIK3CBPIK3CDPIK3CAPIK3CGCHRM2 | |
| SCHEMBL23965933 | 0.88 | PIK3CB (0.43) | PIK3CBPIK3CDPIK3CAPIK3CGCHRM2 | |
| SCHEMBL23966062 | 0.88 | PIK3CB (0.43) | PIK3CBPIK3CDPIK3CAPIK3CGCHRM2 | |
| SCHEMBL23966026 | 0.87 | PIK3CB (0.46) | PIK3CBPIK3CDPIK3CAPIK3CGCHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220017505-A1 | AMINOQUINAZOLINONE AND AMINOISOQUINOLINONE DERIVATIVES AND APPLICATION THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2022-01-20 | — | — | US | disclosed |
| EP-3904343-A1 | AMINO QUINAZOLINONE, AMINO ISOQUINOLONE DERIVATIVES AND APPLICATION THEREOF | Zhejiang University (CN) | 2021-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017505-A1 | AMINOQUINAZOLINONE AND AMINOISOQUINOLINONE DERIVATIVES AND APPLICATION THEREOF | PIK3R5, PIK3CA, PIK3R1 | PIK3CB 9/4885PIK3CD 4/4885PIK3CA 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.